Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLund University

About this trial

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.

Eligibility criteria

Qualifiers

suspicion or confirmed diagnosis of primary breast cancer

signed informed consent

Disqualifiers

lack of signed informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Lund University

Lead sponsor

South Sweden Breast Cancer Group

Collaborator

Mrs. Berta Kamprad Foundation

Collaborator

U-CAN

Collaborator